CNS Pharmaceuticals Inc.

NASDAQ: CNSP · Real-Time Price · USD
4.96
-1.07 (-17.74%)
At close: Aug 15, 2025, 3:59 PM
5.09
2.62%
After-hours: Aug 15, 2025, 04:10 PM EDT

CNS Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
3.31K 4.13K 11.76K 13.07K
Gross Profit
-3.31K -4.13K -11.76K -13.07K
Operating Income
-14.9M -18.87M -15.27M -14.49M
Interest Income
60.26K 27.69K 7.03 9.29
Pretax Income
-14.86M -18.85M -15.27M -14.5M
Net Income
-14.86M -18.85M -15.27M -14.5M
Selling & General & Admin
5.61M 4.77M 5.97M 4.68M
Research & Development
9.29M 14.1M 9.3M 9.35M
Other Expenses
n/a -4.13K n/a 458.62K
Operating Expenses
14.9M 18.86M 15.27M 14.49M
Interest Expense
16.12K 13.8K 7.03K 9.29K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
-14.9M 18.87M 15.27M 14.03M
Income Tax Expense
n/a n/a n/a n/a
Shares Outstanding (Basic)
317.26K 6.22M 2.26M 1.41M
Shares Outstanding (Diluted)
317.26K 6.22M 2.26M 1.46M
EPS (Basic)
-466.44 -60 -134.64 -6.36
EPS (Diluted)
-466.44 -60 -134.64 -6.36
EBITDA
-14.9M -18.86M -15.26M -14.47M
EBIT
-14.87M -18.87M -15.27M -14.49M
Depreciation & Amortization
3.31K 4.13K 11.76K 13.07K